LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

Search

Stevanato Group SpA

Uždarymo kaina

SektoriusSveikatos priežiūra

20.85 1.91

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

20.23

Max

21.02

Pagrindiniai rodikliai

By Trading Economics

Pajamos

10M

49M

Pardavimai

23M

303M

P/E

Sektoriaus vid.

35.5

76.798

Pelnas, tenkantis vienai akcijai

0.162

Dividendų pajamingumas

0.26

Pelno marža

16.205

Darbuotojai

5,521

EBITDA

10M

73M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+31.51% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.26%

2.37%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-922M

5.8B

Ankstesnė atidarymo kaina

18.94

Ankstesnė uždarymo kaina

20.85

Naujienos nuotaikos

By Acuity

50%

50%

166 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

Stevanato Group SpA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-22 23:54; UTC

Pagrindinės rinkos jėgos

Novo Nordisk ADRs Gain on FDA Approval of First GLP-1 in Pill Form

2025-12-22 19:08; UTC

Įsigijimai, susijungimai, perėmimai

Correction to Alphabet to Buy Intersect Article

2025-12-22 17:21; UTC

Įsigijimai, susijungimai, perėmimai

Alphabet to Buy Intersect for $4.75 Billion as AI-Investment Plans Grow -- Update

2025-12-22 16:46; UTC

Įsigijimai, susijungimai, perėmimai

Alphabet to Buy Intersect for $4.75 Billion in Cash

2025-12-22 23:50; UTC

Rinkos pokalbiai

Nikkei May Decline as Yen Rebounds -- Market Talk

2025-12-22 23:42; UTC

Rinkos pokalbiai

Gold Hits Record High Amid Rising Geopolitical Risks -- Market Talk

2025-12-22 22:31; UTC

Uždarbis

Zhejiang Sanhua Intelligent Controls: Higher Demand for Air-Conditioning Components Supported Results >002050.SZ

2025-12-22 22:31; UTC

Uždarbis

Zhejiang Sanhua Intelligent Controls: Higher Demand for Refrigeration Supported Results >002050.SZ

2025-12-22 22:30; UTC

Uždarbis

Zhejiang Sanhua Intelligent Controls Sees 2025 Net CNY3.87B, Up 25% on Year >002050.SZ

2025-12-22 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-22 21:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-12-22 21:37; UTC

Įsigijimai, susijungimai, perėmimai

Capricorn: Project Is Contiguous to Capricorn's Golden Range, Fields Find Tenure

2025-12-22 21:36; UTC

Įsigijimai, susijungimai, perėmimai

Capricorn to Pay A$500,000 Cash, A$4M in New Shares

2025-12-22 21:35; UTC

Įsigijimai, susijungimai, perėmimai

Capricorn to Acquire Prospective Package From Tempest Minerals

2025-12-22 21:35; UTC

Įsigijimai, susijungimai, perėmimai

Capricorn Metals to Buy Yalgoo Project Tenement Package for A$4.5M

2025-12-22 20:54; UTC

Įsigijimai, susijungimai, perėmimai

Middle West Partners Buys Paul Stuart From Mitsui & Co.

2025-12-22 20:52; UTC

Įsigijimai, susijungimai, perėmimai

HCL Technologies: HCLSoftware to Acquire Jaspersoft From Cloud Software Group >532281.BY

2025-12-22 20:09; UTC

Rinkos pokalbiai

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

2025-12-22 19:56; UTC

Rinkos pokalbiai

Crude Gains as U.S. Increases Actions Against Venezuela -- Market Talk

2025-12-22 19:49; UTC

Įsigijimai, susijungimai, perėmimai

A Topsy-Turvy Year for Oracle and the Ellisons Will Bleed into 2026 -- Barrons.com

2025-12-22 19:23; UTC

Rinkos pokalbiai

Mexico's Inflation Seen Easing in Early December -- Market Talk

2025-12-22 19:23; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-12-22 19:02; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2025-12-22 19:02; UTC

Rinkos pokalbiai

Precious Metals Climb to New Heights -- Market Talk

2025-12-22 18:45; UTC

Rinkos pokalbiai

Canadian Trade-Exposed Industries At Forefront of Job Weakness -- Market Talk

2025-12-22 18:30; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Intersect Selling Portion of Assets as Part of Alphabet Deal -- Market Talk

2025-12-22 18:23; UTC

Įsigijimai, susijungimai, perėmimai

What Yogi Berra Would Say About the Talks to Take Over Warner Bros. Discovery -- Barrons.com

2025-12-22 17:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-12-22 17:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-12-22 17:06; UTC

Įsigijimai, susijungimai, perėmimai

Alphabet to Buy Intersect for $4.75B as AI-Investment Plans Grow -- Update

Akcijų palyginimas

Kainos pokytis

Stevanato Group SpA Prognozė

Kainos tikslas

By TipRanks

31.51% į viršų

12 mėnesių prognozė

Vidutinis 27 USD  31.51%

Aukščiausias 30 USD

Žemiausias 24 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Stevanato Group SpA kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

3 ratings

2

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

21.56 / 22.61Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Weak Bullish Evidence

Vidutinės trukmės periodas

Weak Bearish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

166 / 374 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
help-icon Live chat